Document is current
Any future updates will be listed below
-
Authors
Ranada, Shaun I.
Baker, Jacquie R.
Wong, Cameron
Karalasingham, Kavithra
Wilson, Richard J. A.
Phillips, Aaron A.
Sheldon, Robert S.
Edgell, Heather
Raj, Satish R. https://orcid.org/0000-0002-5890-3785
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR000445)
Standing Up to POTS
Natural Sciences and Engineering Research Council of Canada (NSERC) Brain CREATE Program
Alberta Graduate Excellence Scholarship
Alberta Strategy for Patient Oriented SUPPORT Unit
Achievers in Medical Science Doctoral Scholarship
Canadian Institutes of Health Research (CIHR) Fellowship
Heart and Stroke Postdoctoral Fellowship
Canadian Cardiovascular Society Postdoctoral Fellowship
Libin Cardiovascular Institute Post-Doctoral Fellowship in Women’s Cardiovascular Health
CIHR Canadian Graduate Scholarship – Masters
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 5 February 2025
First Online: 26 February 2025
Declarations
:
: The authors declare that they have no conflict of interest. SIR – None. JRB – None. CW – None. KK – None. RW – None. AP – Is a consultant for and shareholder of ONWARD Medical, a publicly traded company commercializing hemodynamic therapeutics for neurological conditions. Honoraria from ADInstruments. RSS – None. HE – None. SRR – Served as a consultant for Lundbeck LLC, Theravance Biopharma, and Amneal Pharma related to neurogenic orthostatic hypotension; Consultant to Regeneron, Antag Pharmaceuticals, argenx BV, and STAT Health Informatics related to postural orthostatic tachycardia syndrome.
